Related Experiment Video
Updated: Mar 23, 2026

10:05
Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate
Published on: January 17, 2018
37.6K
Dense fine speckled indirect immunofluorescence pattern in an Australian population
Andrew Broadfoot1, Terri Sivertsen1, Karl Baumgart1
1Douglass Hanly Moir Pathology, North Ryde, Sydney, NSW, Australia.
Pathology
|March 30, 2016
Summary
The dense fine speckled (DFS) antinuclear antibody (ANA) pattern is uncommon in systemic autoimmune rheumatic disorders. This study found DFS pattern infrequently associated with common autoimmune markers in an Australian population.
Area of Science:
- Immunology
- Autoimmunity
- Clinical Diagnostics
Background:
- The dense fine speckled (DFS) antinuclear antibody (ANA) pattern is gaining attention in diagnostics.
- While not typically linked to systemic autoimmune rheumatic disorders (SARD), DFS has been observed in other inflammatory conditions and in healthy individuals.
Purpose of the Study:
- To determine the frequency of the DFS pattern in an Australian population using indirect immunofluorescence (IIF).
- To assess the association between the DFS pattern and various laboratory autoimmune markers.
Main Methods:
- Retrospective review of ANA tests performed by IIF between July 2012 and June 2014.
- Analysis of DFS-positive samples for concurrent testing of extractable nuclear antigens (ENA), anti-dsDNA, rheumatoid factor (RF), anti-citrullinated protein antibodies (CCP), and anti-phospholipid antibodies.
Main Results:
- The DFS pattern was identified in 5.7% of ANA-positive patients among 181,819 tested.
- Low frequencies of SARD-associated markers were observed: 1.8% for ENA, 0.7% for anti-dsDNA (>9 IU/mL), 6.3% for RF, 4.1% for anti-CCP, and 2 samples for anti-phospholipid antibodies.
Conclusions:
- The DFS pattern, detected by IIF, shows infrequent association with autoimmune markers of SARD in the Australian population.
- Findings align with international studies, suggesting DFS is not a strong indicator for SARD.

